Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of polyethylene glycol (PEG), ascorbic acid (vitamin C), and senna is a low-volume bowel preparation regimen used to cleanse the colon prior to colonoscopy. It combines the osmotic laxative effects of PEG and high-dose ascorbic acid with the stimulant laxative properties of senna. PEG and unabsorbed ascorbic acid act as osmotic agents that draw and retain water in the intestinal lumen, softening stool and promoting watery diarrhea. Senna is metabolized by colonic bacteria into active rhein anthrone, which stimulates the enteric nervous system to enhance peristalsis and downregulates aquaporin-3 expression to inhibit water reabsorption. This combination allows for a reduced volume of bowel preparation solution (typically 1 liter) compared to standard 2-liter or 4-liter PEG regimens, improving patient tolerability and compliance while maintaining high bowel cleansing efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol + ascorbic acid + senna.